Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain NVTR message board posts where the ticker symbol NVTR has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

Related news from
Thu, 12 Dec 2019
20:28:03 +0000
Michael Burry's Top 5 Holdings
'Big Short' investor’s top holdings include 3 retail companies Continue reading...
Wed, 13 Nov 2019
12:10:18 +0000
The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 12) ACADIA Pharmaceuticals Inc (NASDAQ: ACAD ) Allergan ...
Tue, 12 Nov 2019
22:35:31 +0000
Nuvectra® Continuing to Support Current Patients with the Algovita® Implant as Company Voluntarily Files for Chapter 11
Nuvectra Corporation (NVTR) (“Nuvectra” or the “Company”), a neurostimulation medical device company, today announced that it has elected to file a voluntary petition for reorganization under Chapter 11 of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the Eastern District of Texas (the “Court”). The Company intends to use this Court-supervised process to continue its review of a range of options to maximize value and address its financial obligations.
Mon, 28 Oct 2019
14:32:02 +0000
Will Nuvectra (NVTR) Report Negative Q3 Earnings? What You Should Know
Nuvectra (NVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tue, 22 Oct 2019
15:29:55 +0000
Those Who Purchased Nuvectra (NASDAQ:NVTR) Shares A Year Ago Have A 91% Loss To Show For It
It's nice to see the Nuvectra Corporation (NASDAQ:NVTR) share price up 27% in a week. But that doesn't change the fact...
Fri, 18 Oct 2019
12:00:05 +0000
Nuvectra Submits Chemical Composition and Biocompatibility Data to FDA for Virtis™ 
Nuvectra Corporation (NVTR), a neurostimulation medical device company, today announced it has submitted supplementary chemical composition and biocompatibility data to the U.S. Food and Drug Administration (FDA) in support of the Company’s Virtis pre-market approval (PMA) application for the treatment of chronic urinary retention and symptoms of overactive bladder. Fred Parks, Chief Executive Officer, commented, “In April of this year, the FDA requested additional information on chemical composition and biocompatibility regarding our Virtis PMA application. Today, with all requested studies favorably concluded, we submitted the results to the FDA and believe we have fully satisfied their request for supplemental toxicity and biocompatibility data.
Tue, 08 Oct 2019
14:05:02 +0000
Axonics (AXNX) Upbeat on Results of Its ARTISAN-SNM Study
Axonics (AXNX) expects to improve performance on the positive outcome of the study.
Fri, 20 Sep 2019
12:30:00 +0000
Nuvectra® Appoints Jennifer Kosharek as Chief Financial Officer
Nuvectra Corporation (NVTR), a neurostimulation medical device company, today announced the appointment of Jennifer Kosharek as Chief Financial Officer, effective September 16, 2019. Ms. Kosharek will assume the role of Chief Financial Officer after having served as the Company’s interim Chief Financial Officer since May 2019, leveraging over fifteen years of audit and accounting experience and various finance and leadership positions within Nuvectra. Dr. Fred Parks, Nuvectra’s Chief Executive Officer, commented, "I am pleased that Jennifer has assumed the role of Chief Financial Officer on a permanent basis.
Tue, 27 Aug 2019
11:29:00 +0000
The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 26) DURECT Corporation (NASDAQ: DRRX ) Stoke Therapeutics ...
Mon, 26 Aug 2019
20:05:00 +0000
Nuvectra® Exploring Strategic Options to Enhance Shareholder Value
Nuvectra Corporation (NVTR), a neurostimulation medical device company, today announced that its Board of Directors has decided to explore potential strategic alternatives to enhance shareholder value. The Company is currently evaluating all options, including a sale or merger of the Company, to finance the expected growth of the Nuvectra business.
Fri, 23 Aug 2019
13:50:55 +0000
Can We See Significant Institutional Ownership On The Nuvectra Corporation (NASDAQ:NVTR) Share Register?
The big shareholder groups in Nuvectra Corporation (NASDAQ:NVTR) have power over the company. Insiders often own a...
Thu, 22 Aug 2019
07:20:16 +0000
Edited Transcript of NVTR earnings conference call or presentation 31-Jul-19 8:30pm GMT
Q2 2019 Nuvectra Corp Earnings Call
Wed, 31 Jul 2019
22:45:10 +0000
Nuvectra (NVTR) Reports Q2 Loss, Lags Revenue Estimates
Nuvectra (NVTR) delivered earnings and revenue surprises of 23.46% and -0.59%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Wed, 31 Jul 2019
20:01:00 +0000
Nuvectra® Reports Second Quarter 2019 Financial Results
PLANO, Texas, July 31, 2019 -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended.
Wed, 24 Jul 2019
14:32:02 +0000
Will Nuvectra (NVTR) Report Negative Earnings Next Week? What You Should Know
Nuvectra (NVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wed, 17 Jul 2019
12:30:00 +0000
Nuvectra to Report Second Quarter 2019 Financial Results on July 31, 2019
Nuvectra Corporation (NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended June 30, 2019 on Wednesday, July 31, 2019 after market close. The dial in numbers are (844) 882-7830 for domestic callers and (574) 990-9704 for international callers. To access the replay, dial (855) 859-2056 for domestic callers and (404) 537-3406 for international callers and enter access code 3264026.
Wed, 26 Jun 2019
00:33:16 +0000
Is Nuvectra Corporation (NVTR) A Good Stock To Buy?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […]
Mon, 24 Jun 2019
15:55:25 +0000
Should You Be Concerned About Nuvectra Corporation's (NASDAQ:NVTR) Historical Volatility?
If you own shares in Nuvectra Corporation (NASDAQ:NVTR) then it's worth thinking about how it contributes to the...
Wed, 12 Jun 2019
20:05:00 +0000
Nuvectra® to Participate in Two Upcoming Investor Conferences
PLANO, Texas, June 12, 2019 -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that members of management are scheduled to.
Tue, 11 Jun 2019
20:05:00 +0000
Nuvectra Files Regulatory Submission with FDA for Algovita® Full-Body MR-Conditional Approval
Nuvectra Corporation (NVTR), a neurostimulation medical device company, announced today that it has filed its regulatory submission with the U.S. Food and Drug Administration (FDA) for full-body MR-conditional approval for the Company’s Algovita SCS system. Fred Parks, Chief Executive Officer, commented, “We believe full-body MR-conditional approval in the United States, in addition to Algovita’s full-body MR-conditional CE Mark approval, will supplement our existing competitive advantages and expand the number of eligible patients. This submission, pending regulatory approval from the FDA, would position the Company to achieve MR-conditional approval at or around year end 2019 following a 180-day review process.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "VF is the place to be to pick up on new and proven investment ideas." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2019, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards